Testing Adaptive Physical Activity in Stroke

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01042990

Acronym

TAPAS

Enrollment

Registered

2010-01-06

Start date

2008-09-30

Completion date

2011-09-30

Last updated

2010-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Exercise, Balance, Dynamic Gait, Cardiovascular Fitness

Brief summary

Testing Adaptive Physical Activity in Stroke tests the idea that adaptive physical activity (APA) will improve fitness, balance and walking function, daily step activity, and outcomes related to quality of life in individuals with chronic stroke. Adaptive physical activity is an exercise model that combines aerobic exercise with balance and gait training in a socially reinforcing group setting. Individualized homework assignments encourage integration of exercise into daily life routines. Our specific aims are: 1. to determine whether APA improves cardiovascular fitness and metabolic health 2. to measure the effects of APA on gait and balance, ambulatory activity, and ADL function 3. to determine whether APA affects self-reported outcomes related to self-efficacy, fatigue, and stroke-specific quality of life

Interventions

OTHERAdaptive Physical Activity

Structured gait, balance, and progressive walking program performed in a group gym setting 3x/week for 6 months

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Ischemic stroke greater than or equal to 6 months prior in men or women ages 40- or older. Hemorrhagic stroke greater than or equal to one year prior in men or women ages 40-or older. 2. Residual hemiparetic gait deficits. 3. Already completed all conventional inpatient and outpatient physical therapy. 4. Adequate language and neurocognitive function to participate in exercise testing and training (specific screening instruments used.)

Design outcomes

Primary

Measure	Time frame
VO2 Peak	baseline, 3 months, 6 months, and 3 months post-intervention
Berg Balance Scale	baseline, 3 months, 6 months, and 3 months post-intervention
Dynamic Gait Index	Baseline, 3 months, 6 months, and 3 months post intervention
Step Activity Monitoring	Baseline, 3 months, 6 months, and 3 months post-intervention
6 Minute Walks	Baseline, 3 months, 6 months, and 3 months post-intervention

Secondary

Measure	Time frame
Psychosocial questionnaires	baseline, 3 months, 6 months, and 3 months post-intervention

Countries

United States

Contacts

Primary ContactKathleen M Michael, PhD

kmichael@grecc.umaryland.edu410-605-7000

Backup ContactJeffrey Beans, BS

jbeans@grecc.umaryland.edu410-605-7000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026